ABSTRACT
Introduction
Gestational diabetes mellitus (GDM), defined as hyperglycaemia with onset or first recognition during pregnancy, is one of the most common metabolic disorders occurring during pregnancy that affects from 3% to 34% of all pregnancies, depending on the screening criteria and ethnic group [1, 2] . Although GDM symptoms resolve after delivery, it has negative consequences for both mother (e.g. preeclampsia, preterm delivery, caesarean section, elevated risk of developing type 2 diabetes mellitus and cardiovascular disease after pregnancy) and child (e.g. prematurity, macrosomia, hypoglycaemia, polycythaemia, and hypocalcaemia) [3] . Insulin resistance and b cells dysfunction are believed to be two major contributors to the pathogenesis of GDM. Although the precise mechanisms underlying these abnormalities are not fully understood so far, disturbances in the insulin signalling pathway [4, 5] and changes in plasma adipokine levels [6] , as well as enhancement in inflammation [7, 8] and oxidative stress [9, 10] have been demonstrated.
Reactive oxygen species (ROS), including either oxygen radicals such as the hydroxyl radical (•OH), peroxyl radical (ROO•), the superoxide anion radical (O 2
•-), or reactive non-radicals like hydrogen peroxide (H 2 O 2 ) or singlet oxygen ( 1 O 2 ), are highly reactive molecules generated within the cell predominantly as by-products of aerobic respiration and metabolism, which paradoxically can act as a double-edged sword in modulating human physiology. ROS function as second messengers in mammalian cells to regulate signal transduction cascades engaged in cell function, growth, differentiation and death as well as cytokine formation, and angiogenesis [11] . On the other hand, excessive ROS production can attenuate endogenous antioxidant systems leading to oxidative stress, which have detrimental effects on cellular DNA, protein and lipids. Oxidative damage of these biomolecules has been implicated in the pathology and complications of numerous diseases such as cancer, cardiovascular diseases, ischaemic diseases, aging processes and diabetes including GDM. Pregnancy per se is a condition associated with enhanced oxidative stress since the high metabolic demand and elevated requirements of oxygen contributes to increased ROS production in the mitochondria of placenta, thought to be a major source of free radicals at onset of pregnancy and during labour. However, this state is balanced by adequate antioxidant responses. In GDM, when antioxidant defence is impaired then oxidative damage increases. Hyperglycaemia has been directly implicated in the formation of free radicals by the mitochondrial electron-transport chain, enhanced polyol and hexosamine pathway flux, activation of protein kinase C (PKC), and augmented formation of advanced glycation end-products (AGEs) [10] . Moreover, hyperglycaemia-induced oxidative stress has been suggested to play an important role in the aetiology of several congenital anomalies in diabetic pregnancy [12] .
In this review we will summarize the current perspective on how hyperglycaemia induces oxidative stress in GDM and how hyperglycaemia-induced oxidative stress is connected to congenital malformations in diabetic pregnancy.
Hyperglycaemia-induced oxidative stress
Several mechanisms underlying hyperglycaemia-induced oxidative stress during GDM have been proposed so far. High glucose can disrupt the electron transport chain in mitochondria, resulting in the O 2
•-overproduction. Additionally, ROS can be generated through the hexosamine, polyol and PKC pathways as well as in the process of AGEs formation ( Fig. 1 ) [10] .
The hexosamine pathway
The hyperglycaemia-induced hexosamine pathway begins with the rate-limiting enzyme glutamine:fructose-6-phosphate amidotransferase (GFAT) that converts fructose-6-phosphate into glucosamine-6-phosphate ( Fig. 1.4) . In turn, the glucosamine-6-phosphate inhibits glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway that generates NADPH. Hence, the enhanced hexosamine pathway lowers NADPH concentration leading to a reduction of glutathione (GSH) level and increased oxidative stress [13] . The end-product of the hexosamine pathway is uridine diphosphate N-acetylglucosamine (UDP-Glc-NAc), the substrate for N-and O-glycosylation of numerous cellular proteins including transcriptional factors [14] .
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The relationship of the hexosamine pathway with insulin resistance has been established. Indeed, the O-linked N-acetylglucosamine modification of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) has been demonstrated to regulate the post-receptor insulin signalling involved in glucose transport and glycogen storage [15] . Additionally, several studies have revealed that GFAT overexpression in fat and liver causes insulin resistance and deterioration of the b-cell function [16] [17] [18] . Moreover, glucosamine increases the plasminogen activator inhibitor-1 (PAI-1) promoter activity, affecting the development of microvascular diabetic complications such as diabetic nephropathy [14] .
The polyol pathway
Under normal conditions, only approx. 3% of cellular glucose is converted into sorbitol in the polyol pathway, whereas under hyperglycaemic condition approx. 30% of glucose is metabolized in this pathway [19] . The first step of this pathway includes a reduction of glucose to sorbitol by aldose reductase (AR) that utilizes NADPH (Fig. 1.1 and Fig. 2 ). In the second step, sorbitol dehydrogenase (SDH) catalyses oxidation of sorbitol to fructose with concomitant NADH production. The polyol pathway participates in hyperglycaemia-induced oxidative stress by three mechanisms [20] . First, the AR competes with glutathione reductase (GR) for NADPH as a co-factor, thereby the GSH concentration decreases and the cellular antioxidant capacity impairs. Second, an enhanced SDH activity augments the NADH concentration, the substrate for the NADPH-dependent oxidase (NOX), leading to superoxide anion overproduction. Third, fructose can be converted into fructose-3-phosphate (F-3-P) and 3-deoxyglucosone (3-DG). Since both products are more potent nonenzymatic glycation agents than glucose, they can effectively form AGEs.
Maternal hyperglycaemia has been shown to cause a rise in sorbitol concentration in foetal tissue and AR activity in the lenses of diabetic rat foetuses [21, 22] . Alterations in the polyol pathway have also been found in diabetic complications such as cardiomyopathy, neuropathy, nephropathy, and retinopathy [20] . Additionally, a linkage of the AR overexpression to atherosclerosis has been reported in diabetic mice (5), as well as AGEs production (2) . Moreover, glycolysis (3) is increased in the hyperglycaemic state. The enhancement of those pathways leads to higher ROS concentration. GFAT -glutamine:fructose--6-phosphate amidotransferase; Gln -glutamine; Glu -glutamic acid; NAD + /NADH -nicotinamide adenine dinucleotide; NOX -NAD(P)H oxidase; PKC -protein kinase C; TCA cycle -tricarboxylic acid cycle; UDP-Glc-NAc -uridine diphosphate N-acetylglucosamine www.dk.viamedica.pl [23, 24] . To prevent these abnormalities, AR inhibitors (ARI) such as sorbinil, fidarestat, and imirestat, among others, are currently being intensively studied [20] .
PKC pathway
Due to enhanced glycolysis under hyperglycaemic conditions, glyceraldehyde 3-phosphate (G-3-P) overproduction leads to increased dihydroxyacetone phosphate (DHAP) formation. The reduction of DHAP to glycerol 3-phosphate followed by acylation generates diacylglycerol (DAG) [25] . In turn, an increased DAG concentration activates PKC, predominantly PKC-b, -d, and -a isoforms ( Fig. 1.5 ). Hyperglycaemia-induced PKC activation has been detected in heart and superior mesenteric artery of diabetic mice [25, 26] . The relationship between increased PKC pathway and enhanced oxidative stress has been suggested [25] . In fact, it has been shown that PKC-b inhibits endothelial NO synthase (eNOS) expression in endothelial cells [27] , whereas PKC-a activates NOX5 leading to increased super oxide production [28] . Additionally, NOX-mediated ROS overproduction augments peroxynitrite formation and oxidation of tetrahydrobiopterin (BH 4 ), eNOS co-factor, causing eNOS dysfunction through uncoupling its reductase and oxygenase domains [29] .
Advanced glycosylation end-products (AGEs)
In diabetes, high glucose concentration increases the AGEs formation. The AGEs arise mainly from autoxidation of glucose to glyoxal, but also from decomposition and fragmentation of the Amadori products ( Fig. 1.2 ). First reaction in the production of AGEs is the condensation of the carbonyl group of glucose with a free amino group of a protein that results in the formation of a reversible Schiff base. Subsequently, the Schiff base can be converted into a covalently bound Amadori product followed by degradation to 3-deoxyglucosone and methylglyoxal [30, 31] . These reactive dicarbonyl compounds react directly with amino groups of intracellular and extracellular protein forming AGEs. The AGEs cytotoxicity is a consequence of altered physiological function of specific proteins and cellular ROS production. The latter process is related with the activation of the type I cell surface receptor for AGEs (RAGE), belonging to the immunoglobulin superfamily, with subsequent induction of NOX [32] . The AGE-RAGE interaction also causes stimulation of some members of the mitogen-activated protein kinase (MAPK) family such as extracellular signal-regulated kinases (ERK)-1 and -2, and p38, resulting in activation of nuclear factor kB (NF-kB) and subsequently induction of the expression of adhesion molecules, cytokines and chemokines [33] . Pro-oxidant and pro-inflammatory functions of the AGE-RAGE axis have been implicated not only in the development and progression of diabetic micro-and macroangiopathy [33] , but also in normal human labour accompanied by increased oxidative stress, formation of inflammatory mediators (e.g. cytokines) and uterotonic phospholipid metabolites (e.g. prostaglandins) as well as in adverse pregnancy outcomes. In support of this, AGEs significantly increases in vitro release of tumour necrosis factor-a (TNF-a), interleukin IL-1b, IL-6, IL-8, prostaglandin (PG)E2, PGF2a and 8-isoprostane from human placenta and gestational membranes with a concomitant increase in NF-kB p65 activation and ERK 1/2 phosphorylation [34] , and concentrations of AGE-modified products in umbilical cord blood increase with gestation progression and Figure 2 . Contribution of the polyol pathway to increased oxidative stress during hyperglycaemia. 3-DG -3-deoxyglucosone; AGEs -advanced glycation end-products; AR -aldose reductase; F-3-P -fructose-3-phosphate; GR -glutathione reductase; GSH -reduced glutathione; GSSG -oxidized glutathione; NOX -NADPH oxidase; ROS -reactive oxygen species; SHD -sorbitol dehydrogenase www.dk.viamedica.pl in preeclampsia [35] . In regard to a relationship of AGEs with GDM, significantly higher serum AGE levels have been found in diabetic patients [36] . Moreover, increased AGE concentrations have been detected in GDM patients with foetal distress, foetal malformation and stillbirth compared with diabetic patients with normal foetal outcome, suggesting that AGEs may be an important risk factor for abnormal outcome in infants of GDMs [37] .
Indicators of oxidative stress in GDM
Oxidative stress can trigger oxidative damage of essential cellular biomolecules such as DNA, proteins, and lipids (Fig. 3) . Among lipid molecules present in cellular membrane, polyunsaturated fatty acids (PUFAs) are particularly ROS-sensitive since they contain double bonds between two carbon atoms that weaken neighbouring C-H bonds, thus facilitating a hydrogen atom removal during the attack of ROS [38] . Lipid peroxidation proceeds as a free radical mediated chain reaction resulting in the formation of several products such as lipid hydroperoxides (LOOHs), conjugated dienes, alkanes, aldehydes, and isoprostanes (Fig. 3) . An increased LOOH level is a common indicator of oxidative stress [39] . The reactive end-products of lipid peroxidation such as malonyl dialdehyde (MDA) and 4-hydroxy-2-nonenal (4-HNE) can readily react with cellular proteins and DNA, leading to the formation of stable adducts [40] . MDA can react with thiobarbituric acid yielding thiobarbituric acid reactive substances (TBARS), which are quantified to monitor lipid peroxidation. However, MDA is not specific for oxygen radical-induced lipid peroxidation since it can be also produced by cyclooxygenase in enzymatic lipid peroxidation. Additionally, free-radical-catalysed peroxidation of arachidonic acid independent of cyclooxygenase results in formation of PGF2-like compounds, namely F2-isoprostanes. Among them, 8-iso-prostaglandin F2a (8-iso-PGF2a) is an important marker of endogenous lipid peroxidation [41] . The functional consequence of lipid peroxidation is an increase in membrane fluidity and permeability [38] .
Among protein oxidative modifications, the irreversible products are protein carbonyls (PCO) and 3-nitrotyrosine (3-NT) (Fig. 3) . Protein carbonyls are formed on several amino acids residues such as arginine, histidine, lysine, proline, threonine and cysteine. Carbonylation may lead to AGEs formation, starting from condensation of amino group, predominantly at lysine and arginine side chains, and carbonyl generating N-glycoside that is transformed into the Schiff's base and then the Amadori product [42] . The 3-NT is formed between reactive nitrogen species (RNS) and a protein's tyrosine residue. 3-NT is thought to be a highly selective modification since not all tyrosine residues on a target protein can be nitrated [43] . The reversible protein oxidation includes cysteine modification products such as sulphenic acids, nitrosothiols, and s-glutathione. Cysteine is usually oxidized to sulphenic acid, which in turn can undergo S-nitrosylation (-SNO), S-glutathionylation (protein-SSG), S-sulphenation (-SOH) or can be converted into disulphide (S-S-) [43] . These cysteine oxidative modifications are involved in redox regulation of protein functions through ROS and RNS.
Biomarkers of oxidative damage
In GDM, lipid peroxidation products are usually measured as indicators of oxidative stress. Numerous studies have revealed increased MDA and TBARS levels in maternal and cord blood as well as in placenta from pregnancies complicated by GDM (Tab. 1) [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] . Additionally, MDA level has been found to positively correlate with blood glucose concentration [40] . Besides MDA and TBARS, increased serum LOOHs concentration has also been detected in women with GDM (Tab. 1) [59] [60] [61] .
Although there are limited data on protein oxidation in GDM, several studies have demonstrated increased levels of protein damage markers, including PCO, 3-NT, protein hydroperoxides (POOHs), and advanced oxidation protein products (AOPP), in plasma, serum, leukocytes, and placenta in GDM patients (Tab. 1) [9, 51, 62] . Moreover, the positive correlation between POOHs and glycated haemoglobin A 1c (HbA 1c ) has been found in GDM women [62] . By contrast, decreased plasma 3-NT and LOOHs levels in GDM women at 28 weeks of gestation has also been reported [58] . The reasons for that difference are uncertain, but may stem from a relatively small number of patients participating in this study.
Endogenous antioxidants
Endogenous enzymatic antioxidants such as superoxide dismutase (SOD) that generates hydrogen peroxide from superoxide radicals and catalase (CAT) along with glutathione peroxidase (GPX) which decompose hydrogen peroxide are believed to be the first line of defence against ROS propagation, oxidative stress and tissue damage in the organism. Therefore, these enzymes have been studied most frequently of the antioxidant systems during diabetic pregnancy so far (Fig. 3) . It has been demonstrated that CAT activity is reduced in maternal cord plasma as well as in placenta of GDM women (Tab. 2) [53] . The SOD activity has been found to be generally decreased in GDM patients [44, 56, 59, 63, 64] , although there are also studies showing its increased activity in cord blood and placenta of diabetic women (Tab. 2) [9, 53] . GPX activity has been reported to be decreased in cord blood [53] and unaltered in placenta of GDM women [9, 53] . It is important to note that the most significant differences in GPX activity have been seen in maternal blood. Discrepancies among studies may arise from the variety of biological material analysed (i.e. whole blood, plasma, or erythrocytes), the different diagnostic GDM criteria and/or sample size used.
Human studies on the importance of non-enzymatic antioxidants, i.e. tocopherol (vitamin E), ascorbate (vitamin C), and carotenoids (vitamin A), in GDM are both contradictory and confusing [44, 50, 54, 55, [63] [64] [65] [66] [67] [68] [69] .
The vitamin E concentration has been found to be increased or decreased or unchanged by diabetes (Tab. 2). These inconsistencies may be partially explained by different diagnostic GDM criteria and small sample sizes. In the case of vitamin C, the majority of research has demonstrated its diminished plasma level in GDM women, but there is one study showing its increased serum level in GDM patients (Tab. 2) [44] . The vitamin A concentration has been generally found to be unchanged in GDM patients, however, Suhail et al. [50] have revealed its reduced plasma concentration (Tab. 2).
Oxidative stress and adverse outcomes in diabetic pregnancy
The increased rate of foetal malformations in diabetic pregnancy is a major clinical issue, but the precise mechanisms underlying these changes currently remain poorly understood. Oxidative stress is considered as an important pathway by which diabetes may affect the normal development of the embryos. Early embryonic development is characterized by relative immaturity of antioxidant defence mechanisms, thus, predisposing the embryo to increased risk of ROS-induced oxidative damage of proteins, DNA, and lipid. In support of the significance of ROS in the embryonic maldevelopment of diabetic pregnancy, the addition of SOD to "diabetic culture medium" containing high levels of glucose and ketone bodies has been shown to reduce hyperglycaemia-induced development anomalies in 10.5-day-old rat embryos in culture [70] . Other antioxidant enzymes or low-molecular-weight antioxidants added to the diet or in vitro have been also reported to diminish embryonic dysmorphogenesis in pregnant diabetic rats [71] [72] [73] .
Among diabetic pregnancy-induced malformations, defects in neural tube and heart are the most commonly occurring [12, 74] . Studies on the role of genetic factors involved in the development of neural tube defects (NTDs) in a mouse model of diabetic em- bryopathy have revealed that NTDs are associated with deficient expression of Pax-3, the gene encoding a transcription factor that is required for neural tube closure and that is expressed in neuroepithelium, neural crest, and somitic mesoderm [75] . Decreased Pax-3 expression appears to be involved in enhanced apoptosis, the central mechanism in the induction of diabetic embryopathy, since apoptotic cells have been found at sites of neural tube defects in embryos carrying null mutation of the Pax-3 gene [75] . These findings indicate that the Pax-3 gene contributes to NTDs. Further studies in this field have disclosed that maternal hyperglycaemia increases the hypoxic state of the embryo, leading to inhibition of Pax-3 expression and increase of NTDs and this process is associated with increased oxidative stress [76] . Hence, diabetes-induced oxidative stress may also change embryonic gene expression, contributing to the embryonic damage. Lately, new data have emerged connecting hyperglycaemia-induced oxidative stress to inducible NOS (iNOS) up-regulation and nitrosative stress in diabetic NTDs. In this regard, it has been presented that suppression of oxidative stress with the use of both in vitro recombinant human soluble SOD (SOD1) treatment and in vivo SOD1 overexpression inhibited hyperglycaemia-increased iNOS expression and consequent nitrosative stress along with apoptosis in diabetic embryopathy [77] .
Congenital heart anomalies, including endocardial cushion (EC) defects, persistent truncus arteriosus (PTA) and ventricular septal defects (VSD), are one of the most common malformations in offspring of diabetic mothers, but their molecular basis remains obscure [74] . Recently, maternal diabetes-induced congenital heart defects have been demonstrated to associate with the ultrastructural changes, i.e. the presence of swollen mitochondria and disorganized myofilaments with poorly developed adherence junctions, in cardiomyocytes of the ventricular wall as well as with the down-regulation of several genes, i.e. Bmp4, Msx1, and Pax3, involved in development of cardiac neural crest [78] . The role of oxidative stress in the cardiac defects in embryos of diabetic pregnancy has been proposed by Wang et al. [79] who have found that SOD1 overexpression in transgenic mice attenuates oxidative stress and 
Conclusions
GDM is a problem of great clinical importance underlying the development of numerous adverse maternal and perinatal outcomes. It is now generally accepted that an increased oxidative stress contributes to the pathogenesis of GDM and hyperglycaemia is a crucial factor that triggers this process through several mechanisms such as the polyol pathway, the hexosamine pathway, PKC activation, AGEs formation, and the mitochondrial electron transport chain. Although alterations in biomarkers of oxidative stress have been found in GDM women, more experimental evidence is required to help resolve some controversies regarding levels of both antioxidant enzymes and non-enzymatic antioxidants in maternal and cord plasma, as well as in placenta. Moreover, there is still an urgent need to determine the precise molecular mechanisms underlying the relationship between oxidative stress and major congenital malformations such as defects in neural tube and heart in diabetic pregnancy.
